Primary amenorrhea: locate the problem and choose the next step
Work through primary amenorrhea with anatomy, hormone feedback, responsive visual models, and original cases that explain the next useful clinical step.
No menstrual bleeding is an observation, not a location. The problem may involve central signaling, gonadal hormones, uterine tissue, or an outflow route. Build the workup by asking what is present, what is functioning, and what needs attention first.
Decide what needs evaluation now
Primary amenorrhea means that menstrual bleeding has not begun. Evaluate no menarche by age 15 even when breast development appears normal. Evaluate absent breast development by age 13. ASRM also addresses very early breast development: when it begins before age 10, no menses within five years warrants evaluation. Pubertal timing, progression, and symptoms all matter. [1]
Do not confuse breast development with pubic hair. Breasts indicate estrogen exposure; pubic hair reflects androgen-sensitive tissue effects and can arise with adrenarche. A patient can therefore have pubic hair without adequate ovarian estrogen production. Neither finding alone proves that the uterus exists or that blood can leave it.
Begin with a respectful history, including pubertal timing, growth, chronic illness, nutrition, exercise, stress, medications, headaches, vision changes, pain, and possible pregnancy. Offer confidential discussion appropriate to the patient's age and setting. Hormone exposure from medications also matters when interpreting breast development.
Pregnancy may be possible before the first recognized menstrual bleed because ovulation can occur first. Do not skip pregnancy assessment when conception is biologically possible. A negative urine test is not an absolute guarantee in every circumstance; serum hCG and appropriate clinical evaluation may be needed when timing, symptoms, or sample conditions leave concern. [1]
Some findings override a routine outpatient sequence. Severe pain, hemodynamic instability, urinary retention, neurological symptoms, profound bradycardia, orthostatic hypotension, or electrolyte abnormalities require prompt assessment. Identifying a likely endocrine mechanism does not make an unstable patient safe to send home. [6][9]
Does a family history of late menarche justify skipping evaluation at 15?
No. It makes constitutional delay one possibility, but it does not exclude anatomical, nutritional, systemic, or endocrine causes. An indicated evaluation should proceed while the family history informs interpretation. [1]
Locate the obstruction before naming the procedure
Cyclic pain without external bleeding raises concern for retained blood, but it does not prove ovulation in every cycle. Examine and image the tract. Hematocolpos means blood within the vagina; hematometra means blood within the uterus. The collection and the point where the tract stops help locate the barrier. [7][9]
An imperforate hymen can appear as a tense, bluish membrane at the vaginal opening, with blood distending the vagina behind it. A transverse vaginal septum lies within the canal: the introitus may be patent while a higher barrier prevents drainage. Both can produce pain, but they occupy different anatomical levels.
If the vagina is patent and blood accumulates in the uterus above an absent or obstructed cervical communication, consider a cervical anomaly. Do not apply a hymenal procedure to a cervical problem. Complex anomalies require detailed imaging and an experienced adolescent gynecologic team; definitive management depends on the anatomy and patient-specific risks.
Visible bleeding does not exclude every obstruction. In a duplicated tract, one side can drain while an obstructed hemivagina retains blood. A pattern combining an obstructed hemivagina with an ipsilateral renal anomaly is often called OHVIRA. Persistent unilateral cyclic pain therefore deserves assessment even when some menstrual bleeding occurs. [9]
Use the anatomical model to choose the level of the barrier. Predict where blood would accumulate before changing the control. A cervical barrier retains blood above the cervix; a vaginal barrier can retain it in the upper vagina as well. The diagram simplifies geometry and is not a substitute for clinical imaging.
Avoid casual advice to make a simple incision or drain a collection without defining the anomaly. Appropriate management aims to relieve obstruction while reducing injury, infection, restenosis, and other complications. Acute urinary or systemic symptoms may change the urgency of care. The lesson teaches localization, not a procedural recipe. [7][9]
A patent introitus, a short distal canal, and blood above a vaginal barrier: where is the problem?
The demonstrated barrier is within the vagina, not at the hymenal opening. A transverse septum is one relevant diagnosis. Use imaging to define its level and associated anatomy before planning management.
Confirm an absent uterus, then compare the evidence
A report that the uterus was not visualized is not equivalent to confirmed agenesis. Low estrogen can leave a small uterus difficult to see, and poor views can further limit ultrasound. When the anatomy is uncertain, obtain appropriate repeat or additional assessment rather than assigning a permanent diagnosis from a limited image. [1]
With reliably confirmed Mullerian underdevelopment and normal ovarian function, MRKH becomes an important consideration. The ovaries arise through a different developmental pathway and may contain follicles, make estrogen, and support breast development despite absent or underdeveloped uterine and upper vaginal structures. A typical karyotype is 46,XX. [3]
MRKH can be isolated or occur with other anomalies. Renal abnormalities are particularly relevant; vertebral, hearing, or other findings may also guide assessment. Do not turn an association into a universal rule or assume that every person needs an identical set of procedures. The clinical evaluation should define the actual pattern.
Some patients have uterine remnants containing functional endometrium. Those remnants can respond to ovarian hormones and can cause cyclic pain, particularly with impaired drainage. Thus, pain does not automatically invalidate an MRKH diagnosis. The question becomes which tissue remains and whether it can drain. [1][9]
Complete AIS provides a different explanation for absent Mullerian structures. Testes formed, and fetal AMH acted, but androgen response is impaired. Breast development can occur through estrogen action. Appropriately interpreted testosterone, gonadal assessment, and karyotype help distinguish this from MRKH. Pubic hair may contribute to the pattern but is not a stand-alone verdict. [2]
Care includes clear information, privacy, psychological support when useful, and discussion of sexual and reproductive goals without assumptions. Vaginal treatment is not automatically required on the day of diagnosis. Readiness, preferences, symptoms, and specialist counseling matter. Avoid describing a person as incomplete because a structure is absent.
What is stronger evidence than a hair-based shortcut?
The combination of reliable anatomy, gonadal findings, appropriate testosterone testing, and genetic information is stronger. A 46,XX patient with follicular ovaries and Mullerian underdevelopment differs from a 46,XY patient with testes and impaired androgen action. [1]
Pair estradiol with FSH
If estrogen exposure is inadequate, use the feedback relationship to locate the problem. Low estradiol with high FSH supports primary gonadal dysfunction: the pituitary is increasing stimulation because gonadal feedback is insufficient. Low estradiol with low or inappropriately normal FSH suggests insufficient central stimulation. [1]
The word normal on a laboratory report can be misleading. A broad reference interval is not the same as an appropriate response to the patient's physiology. When estradiol is very low, an FSH that fails to rise can be important even if the number sits within the printed interval. Interpret age, puberty, medications, and the full clinical pattern.
Turner syndrome is one cause of gonadal dysfunction, not a diagnosis made from high FSH alone. Short stature or characteristic features may support evaluation, but phenotype and ovarian function vary. Mosaic patients may have some spontaneous breast development. Adrenal androgen effects can preserve pubic hair despite inadequate ovarian estrogen production. [5]
Turner-associated care extends to cardiovascular and renal assessment and longer-term endocrine needs. Do not use a single annual imaging interval for every patient without considering the actual cardiovascular findings and specialist recommendations. An association table should prompt appropriate assessment, not substitute for an individualized plan.
A 46,XY patient can also have a uterus and high-FSH gonadal dysfunction. In complete gonadal dysgenesis, ineffective fetal AMH allowed Mullerian structures to persist, while inadequate gonadal steroids impair puberty. The diagnosis has both hormone-replacement and dysgenetic gonadal tumor-risk implications. [4]
Use the feedback model to compare two patients with the same low estradiol but different FSH. Ask what the pituitary response implies before revealing the suggested next assessment. This model localizes a pattern; it cannot distinguish every hypothalamic, pituitary, ovarian, genetic, or treatment-related cause.
Does high FSH show that the ovary is responding well?
No. A high signal can be compensation for a poorly responding target. Pair the signal with its expected product: high FSH and low estradiol supports inadequate gonadal feedback, not successful ovarian function.
Investigate central causes without assuming the answer
Low energy availability, intensive exercise, stress, or systemic illness can suppress GnRH-associated reproductive signaling. Functional hypothalamic amenorrhea is a diagnosis made after relevant alternatives are assessed. Body size alone does not establish or exclude it; the history, hormone relationships, nutritional state, and medical stability matter. [6]
Ask about persistent severe headache, vomiting not otherwise explained, visual changes, excessive thirst or urination, and other signs of pituitary disease. A central hormone pattern with neurological warning signs can require pituitary-focused MRI. Do not attribute every low-gonadotropin result in an athlete to exercise.
Look beyond the reproductive axis when the evidence calls for it. Low free thyroxine without an appropriate TSH rise and low morning cortisol with inadequate ACTH can accompany broader central hormone deficiency. A low estradiol and non-elevated FSH pattern plus other deficient axes needs pituitary-focused assessment, not an automatic functional-suppression label. [10]
Prolactin and thyroid testing are part of the evaluation. Galactorrhea is not required for clinically relevant hyperprolactinemia. A mildly elevated prolactin should be confirmed and interpreted with sampling conditions, medications, pregnancy, thyroid function, and other causes. Persistent unexplained elevation needs further assessment. [1]
High TSH with low free T4 supports primary hypothyroidism. Thyroid disease can contribute to menstrual dysfunction and prolactin elevation. Treat the demonstrated disease and reassess, while remaining alert to coexisting causes. One abnormal test does not automatically explain every finding in the patient.
Congenital GnRH deficiency can occur with anosmia, as in a Kallmann pattern, or without it. Congenital inability to smell and absent olfactory bulbs support a developmental explanation when the reproductive hormone pattern is central. Constitutional delay remains a different possibility, but family history and delayed bone age do not prove it before other causes are considered. [1]
When low energy availability is established, treatment addresses nutrition, exercise balance, and psychological or behavioral contributors with an appropriate team. Profound bradycardia, hypotension, orthostasis, or electrolyte abnormalities may require inpatient care. Severe undernutrition also requires supervised nutritional rehabilitation and monitoring; focusing on a single laboratory value must not distract from the whole patient's safety. [6]
No galactorrhea, but repeatedly elevated prolactin: can the prolactin still matter?
Yes. The absence of milk discharge does not negate persistent biochemical hyperprolactinemia. Confirm and investigate its cause rather than using an absent symptom as an exclusion rule.
Interpret tests as evidence, then choose the next action
Bleeding, pain and ovulation are different observations. A progesterone measurement can support recent ovulation when obtained at an appropriate time, roughly one week before an expected period. A single low result at an unknown phase cannot exclude ovulation. Do not use monthly pain or retained blood as a substitute for phase-appropriate evidence. [11]
A progestogen-withdrawal response is not a complete diagnosis. External withdrawal bleeding supports a responsive, estrogenized endometrium with an available outflow route. It can be compatible with anovulation, but it does not prove constitutional delay or justify stopping an otherwise indicated evaluation. [1]
No withdrawal bleeding also has several explanations. Low estrogen may leave too little endometrium to shed; an endometrial or outflow problem may prevent bleeding. Even sequential hormone testing needs context. Do not diagnose intrauterine adhesions from a negative challenge alone, particularly without relevant history or anatomical assessment.
Androgen excess adds another branch of evaluation. Chronic anovulation with hyperandrogenic features has a different pattern from profound hypoestrogenic central suppression. Do not diagnose or exclude a chronic hyperandrogenic ovulatory disorder solely from body size, an LH-to-FSH ratio, or one ovarian image. A partial adrenal enzyme defect is also a consideration in the appropriate setting. [1]
Bone health deserves explicit attention when hypoestrogenism or low energy availability persists. Prolonged amenorrhea, severe nutritional deficit, or a stress fracture may justify bone-density assessment. An oral contraceptive prescribed solely to create bleeding or improve bone density does not correct the underlying energy deficit and can mask return of spontaneous cycles. [6]
Use the actual anatomy to plan hormone care. A retained uterus in gonadal dysgenesis may respond to estrogen and later requires appropriate progestogen management. An absent uterus changes endometrial considerations. Neither the karyotype alone nor a remembered syndrome slogan should replace the documented anatomy. [1][4]
Finish each case by stating what is established, what remains uncertain, and what action follows. For example: low estradiol with non-elevated FSH supports a central pattern, but neurological symptoms determine whether imaging is needed. That statement is more useful than naming a condition before examining its supporting evidence.
Transfer the approach to someone whose periods started and then stopped: what changes?
The history now describes secondary rather than primary amenorrhea, but pregnancy assessment and the anatomy-hormone-feedback framework still apply. Prior bleeding makes some congenital explanations less likely; it does not remove the need to assess new endocrine, nutritional, medication-related, or structural causes. [1]
Predict your answer before opening the choices. The cases are original educational examples. Check the explanation for your choice, then compare the closest alternative without treating a simplified case as personal medical advice.
Case 1
Show answer and explanations for case 1
A. Pelvic ultrasonography (Best answer)
Absent menarche at 15 warrants evaluation despite a family history of late menarche. Pelvic imaging can assess the uterus and retained fluid; cyclic symptoms call for anatomical assessment.
B. Prolactin measurement (Why this does not fit)
Prolactin is part of an amenorrhea evaluation. Prolactin does not locate a possible pelvic collection; cyclic pressure calls for anatomical assessment.
C. Karyotype analysis (Why this does not fit)
It can help classify selected gonadal or confirmed uterine-development patterns. Anatomy and hormone findings should direct genetic testing; cyclic pressure first calls for pelvic assessment.
D. FSH and estradiol measurement (Why this does not fit)
FSH paired with estradiol can distinguish gonadal from central hormone patterns. Those values do not show whether blood is retained; cyclic pressure calls for anatomical assessment.
Takeaway: Family history does not defer evaluation at 15; cyclic symptoms with estrogen exposure make pelvic anatomy an early priority.
A. FSH and estradiol measurement (Why this does not fit)
They help localize low-estrogen states to gonadal or central dysfunction. They cannot exclude pregnancy; possible conception requires pregnancy testing first.
B. Pregnancy test (Best answer)
An initial ovulation can occur before the first recognized menstrual bleed. Intercourse makes pregnancy testing necessary before attributing amenorrhea to another cause.
C. TSH and prolactin measurement (Why this does not fit)
Thyroid disease and hyperprolactinemia can disrupt menstruation. Neither excludes a pregnancy after intercourse; pregnancy testing comes first.
D. Repeat pelvic ultrasonography (Why this does not fit)
The prior study documents a developed uterus. Uterine anatomy does not exclude pregnancy; possible conception requires pregnancy testing.
Takeaway: Conception can follow ovulation before the first recognized menstrual period.
A. Obtain serum hCG and perform same-day pelvic assessment (Best answer)
Dilution and timing can limit a negative urine result. Worsening unilateral pain warrants timely pelvic assessment alongside serum hCG testing.
B. Perform pelvic ultrasonography and omit further hCG testing (Why this does not fit)
Pelvic imaging can investigate structural and pregnancy-related causes of pain. Early pregnancy may not be resolved by imaging alone; serum hCG remains necessary when urine testing is uncertain.
C. Repeat first-morning urine hCG before routine pelvic imaging (Why this does not fit)
A concentrated sample can improve urine-test sensitivity. It delays assessment of worsening focal pain; symptomatic pregnancy concern warrants timely serum testing and pelvic evaluation.
D. Order serial serum hCG tests and defer pelvic assessment (Why this does not fit)
They can help interpret an early pregnancy after an initial serum result. Worsening focal tenderness requires timely pelvic assessment rather than laboratory follow-up alone.
Takeaway: A potentially dilute negative urine result does not close the pregnancy assessment when focal pain persists.
A. Cervical canal reconstruction (Why this does not fit)
A patent cervical canal has allowed blood into the vagina. The demonstrated interruption lies at the vaginal outlet, not the cervix. Blood downstream of a patent structure places the barrier farther along the tract.
B. Vaginal reconstruction for distal agenesis (Why this does not fit)
A developed vagina is distended with blood down to the membrane. The canal exists and the barrier is a thin hymenal membrane. An existing obstructed canal does not require reconstruction for an absent segment.
C. Transverse vaginal septum resection (Why this does not fit)
A transverse septum lies within the vagina, above an available distal segment. Assessment found no higher band and places the sole barrier at the opening. Treat the identified hymenal membrane rather than an absent internal septum.
D. Hymenectomy (Best answer)
Blood fills the vagina below a patent cervix and ends at the membrane at the opening. The obstruction is hymenal, so a hymenal procedure addresses the demonstrated level. Define the anatomy before selecting the operation.
Takeaway: Localize the barrier from the collection and examination before selecting the structure to treat.
It would block passage from the uterus into the vagina. The cervix communicates with the proximal blood-filled vagina; the obstruction is farther downstream.
B. Imperforate hymen (Why this does not fit)
It would obstruct at the vaginal opening. The opening and distal lumen are patent; the barrier lies several centimeters inside the vagina.
C. Transverse vaginal septum (Best answer)
The hymenal opening and 3-cm distal vaginal lumen are patent. Blood fills the proximal vagina above a discrete band; that pattern localizes a transverse vaginal septum.
D. Distal vaginal atresia (Why this does not fit)
Distal vaginal atresia involves an absent or solid vaginal segment. A formed distal lumen ends at a discrete thin band; a septum better fits that anatomy.
Takeaway: A patent distal vagina with blood above an internal band localizes a transverse vaginal obstruction.
A. Arrange pelvic MRI and adolescent gynecologic evaluation (Best answer)
Blood is in the uterus without a vaginal collection, placing the suspected interruption near the cervix. MRI and specialist review can define the cervical communication; complex obstruction requires anatomical planning.
B. Plan isolated hymenal surgery after repeat ultrasound (Why this does not fit)
The hymenal opening is patent. Uterine blood without vaginal distension points above the hymen; treatment must target the demonstrated level.
C. Perform office hysteroscopy through the presumed cervical canal (Why this does not fit)
Transcervical hysteroscopy requires a navigable cervical route. The cervical anatomy is unresolved; detailed mapping should precede attempted instrumentation.
D. Begin serial vaginal dilation and reassess the cavity (Why this does not fit)
Vaginal dilation acts on vaginal tissue. The vagina is already patent and the cervical connection is uncertain; cervical mapping comes first.
Takeaway: Uterine blood above a patent vagina calls for detailed cervical mapping and specialist planning.
A. Bilateral hematocolpos with neither side patent (Why this does not fit)
Neither tract would provide the observed menstrual drainage. A right canal drains during menses; one patent side can coexist with contralateral obstruction.
B. Two patent hemivaginas with an isolated left ovarian cyst (Why this does not fit)
An ovarian cyst can cause unilateral pain. The left collection enlarges during menses beside a duplicated uterine tract; its relationship to flow needs anatomical explanation.
C. Left hematocolpos with a patent right hemivagina (Best answer)
The patent right outflow tract can drain menstrual blood. Blood retained in an obstructed left hemivagina explains cyclic pain and fits the ipsilateral renal anomaly.
D. Right hematocolpos with a patent left hemivagina (Why this does not fit)
The right tract is described as patent and draining. The enlarging left collection and left-sided pain point to left retention; match the obstructed side to the findings.
Takeaway: Visible menses from one tract can coexist with blood retained in an obstructed hemivagina on the side of a renal anomaly.
A. Use a progestogen challenge as the sole uterine test (Why this does not fit)
Low estrogen can leave too little endometrium for withdrawal bleeding. It would not distinguish a small hypoestrogenic uterus from absent anatomy; imaging remains necessary.
B. Order testosterone and karyotype without repeating anatomy imaging (Why this does not fit)
They can distinguish causes after true uterine absence is established. The uterus and ovaries were poorly visualized; reliable anatomy must be established before using an absent-uterus pathway.
C. Repeat optimized pelvic imaging and assess the central hormone pattern (Best answer)
Low estradiol with non-elevated FSH supports inadequate central stimulation. An empty-bladder scan with poor views does not establish uterine absence; repeat or additional imaging is needed.
D. Classify Müllerian agenesis from the scan and assess renal anatomy (Why this does not fit)
Confirmed Müllerian anomalies can have renal associations. Poor views and low estrogen make uterine nonvisualization uncertain; confirm pelvic anatomy before classifying agenesis.
Takeaway: Low estrogen and limited imaging can make a small uterus difficult to see; anatomy and endocrine function both need clarification.
A. Bleeding within an obstructed uterine remnant (Best answer)
A uterine remnant containing functional endometrium can respond to ovarian hormones. Absent drainage can retain blood within the remnant; cyclic retention can produce pain.
B. Blood trapped behind an intact cervical canal (Why this does not fit)
It would require a formed uterine cavity and cervical canal. MRI shows an isolated uterine bud without a formed cervix; the remnant itself is the relevant site.
C. Repeated hemorrhage within an ovarian cyst (Why this does not fit)
A hemorrhagic cyst can cause pelvic pain. MRI places the blood-signal cavity inside a uterine bud and shows a separate unremarkable ovary; location governs interpretation.
D. Pain from a nonfunctional fibrous uterine bud (Why this does not fit)
A nonfunctional fibrous bud would lack a bleeding endometrial cavity. A blood-signal cavity in the bud supports functional tissue with impaired drainage.
Takeaway: A functional obstructed uterine remnant can cause cyclic pain even when a formed uterus is absent.
A. A: complete gonadal dysgenesis; B: MRKH (Why this does not fit)
Nonfunctional gonads would generally provide inadequate testosterone and ineffective fetal AMH. Testes, male-range testosterone, and absent uterus favor formed gonads with impaired androgen action.
B. A: complete androgen insensitivity; B: MRKH (Best answer)
Testes produce testosterone, but absent virilization suggests impaired androgen action. Follicular ovaries and 46,XX with Müllerian underdevelopment support MRKH; classify absent-uterus patterns by gonads and hormones.
C. A: 5-alpha-reductase deficiency; B: MRKH (Why this does not fit)
Testes and 46,XY can occur with 5-alpha-reductase deficiency. Preserved testosterone receptor action often permits pubertal virilization; A's absent virilization favors impaired androgen response.
D. A: complete androgen insensitivity; B: cervical atresia (Why this does not fit)
A formed uterine body would remain above the cervical obstruction. A formed uterus is absent despite functioning ovaries; that anatomy favors Müllerian underdevelopment.
Takeaway: Combine anatomy, gonads, hormones, chromosomes, and pubertal response; hair alone is not a final test.
A. Hypothalamic suppression (Why this does not fit)
FSH is low or inappropriately normal for the low estradiol. FSH is markedly high twice; compensatory elevation favors a gonadal rather than central level.
B. Anterior pituitary gonadotropin deficiency (Why this does not fit)
It would predict insufficient FSH secretion. FSH is repeatedly elevated; a strong pituitary signal with low estradiol points downstream.
C. Isolated outflow obstruction (Why this does not fit)
It blocks the exit of menstrual blood. It does not cause repeatedly high FSH with low estradiol and little breast development.
D. Primary gonadal dysfunction (Best answer)
Gonadal estrogen output is inadequate for pubertal development. The pituitary is increasing stimulation despite low output; high FSH with low estradiol favors gonadal dysfunction.
Takeaway: Low estradiol with repeatedly high FSH localizes inadequate steroid feedback to the gonads.
FSH has not risen appropriately despite very low estradiol, indicating deficient central stimulation. Low TSH response and low ACTH accompany low target hormones; multiple deficient axes favor pituitary dysfunction.
B. Primary ovarian dysfunction (Why this does not fit)
Reduced ovarian feedback would generally raise FSH. FSH remains non-elevated and other pituitary-controlled axes are deficient; the pattern is central.
C. Functional hypothalamic suppression (Why this does not fit)
Low estradiol with non-elevated FSH can occur with hypothalamic suppression. Additional thyroid and adrenal axis deficits require evaluation for broader pituitary disease.
D. Primary thyroid dysfunction (Why this does not fit)
TSH would generally rise when free T4 falls. TSH is not elevated, and ACTH and FSH responses are also inadequate; multiple axes suggest pituitary dysfunction.
Takeaway: A printed-normal FSH can be inappropriate when estradiol is low; additional pituitary-axis deficits favor pituitary dysfunction.
A. Urgent medical assessment for stabilization and supervised nutrition (Best answer)
Energy restriction can suppress central reproductive signaling. Severe bradycardia, orthostasis, and electrolyte imbalance warrant urgent assessment for supervised stabilization.
B. Outpatient estrogen induction with unrestricted training (Why this does not fit)
Estrogen would not correct bradycardia or electrolyte disturbance. Medical instability and energy deficit require supervised assessment before an outpatient hormone plan.
C. Routine endocrine follow-up after training is reduced (Why this does not fit)
Reducing energy expenditure can contribute to restoring energy balance. Current orthostasis, severe bradycardia, and hypokalemia require prompt medical evaluation.
D. Intensive outpatient nutrition with reassessment in several days (Why this does not fit)
Restoring energy availability addresses a likely contributor to reproductive suppression. Marked bradycardia, symptomatic orthostasis, and low potassium require urgent medical assessment now.
Takeaway: A plausible functional hormone mechanism does not reduce the urgency of bradycardia, orthostasis, and electrolyte disturbance.
A. Karyotype analysis before cranial imaging (Why this does not fit)
It can help classify selected gonadal or developmental disorders. Visual-field change and headache with a central hormone pattern warrant cranial assessment first.
B. Pituitary-focused brain MRI with visual assessment (Best answer)
Low estradiol without a gonadotropin rise suggests central dysfunction. Progressive peripheral visual difficulty with headache warrants pituitary-focused MRI and visual assessment.
C. Pelvic MRI to reassess uterine anatomy (Why this does not fit)
It can clarify uncertain uterine or outflow anatomy. Central hormones plus visual-field symptoms direct imaging toward the brain and pituitary.
D. Nutritional intervention followed by interval observation (Why this does not fit)
It is important when low energy availability is established. Progressive headache and visual symptoms require investigation for intracranial disease.
Takeaway: Central reproductive suppression with progressive headache and visual-field symptoms warrants pituitary-focused imaging.
A. Repeat prolactin alone after several months (Why this does not fit)
A mild single elevation should be confirmed under appropriate conditions. Repeated rested samples confirm monomeric elevation; further delay should not replace pituitary assessment.
B. Repeat macroprolactin testing as the sole investigation (Why this does not fit)
Macroprolactin can cause elevated total assay results with limited biological activity. Monomeric prolactin remains high; persistent active elevation requires pituitary assessment.
C. Repeat thyroid testing as the sole investigation (Why this does not fit)
Hypothyroidism can raise prolactin. Hypothyroidism has been excluded while monomeric prolactin remains elevated; another cause needs investigation.
D. Pituitary MRI (Best answer)
Two rested samples and elevated monomeric prolactin establish persistent hyperprolactinemia. Galactorrhea is not required; persistent unexplained elevation warrants pituitary imaging.
Takeaway: Persistent biologically active hyperprolactinemia warrants pituitary assessment even without galactorrhea.
A. Test macroprolactin and omit repeat total prolactin (Why this does not fit)
It can clarify persistent mild elevation, especially without symptoms. The initial result may be transient; repeat prolactin before interpreting fractionation as the whole workup.
B. Repeat rested prolactin, then assess persistent elevation (Best answer)
It is a mild single elevation after stress and exertion. Repeat prolactin under suitable conditions, then investigate persistent elevation; confirm mild abnormalities before imaging.
C. Start a dopamine agonist before confirming the result (Why this does not fit)
Persistent biologically relevant hyperprolactinemia has not been established. Confirm the abnormality and its cause before treating an isolated mild assay result.
D. Obtain pituitary MRI before repeating prolactin (Why this does not fit)
Persistent unexplained hyperprolactinemia warrants pituitary assessment. Persistence has not been shown; a rested repeat should precede imaging for this isolated mild result.
Takeaway: Confirm a mild, context-sensitive prolactin elevation before assigning a pituitary cause.
A. Obtain pituitary MRI before addressing thyroid disease (Why this does not fit)
Persistent unexplained prolactin elevation or neurological findings can justify imaging. Overt hypothyroidism is documented without neurological warning signs; treat it and reassess prolactin.
B. Begin dopamine-agonist treatment and leave thyroid function unchanged (Why this does not fit)
The TSH and free T4 results establish primary hypothyroidism. Leaving thyroid disease untreated prevents testing whether it caused the mild prolactin elevation.
C. Treat hypothyroidism and repeat prolactin with thyroid tests (Best answer)
High TSH with low free T4 establishes primary hypothyroidism. Thyroid disease can raise prolactin; persistence after correction would prompt further assessment.
D. Repeat prolactin without treating the thyroid abnormality (Why this does not fit)
Follow-up prolactin can show whether the elevation persists. The confirmed thyroid disease requires treatment; reassess prolactin after thyroid correction.
Takeaway: Overt primary hypothyroidism can contribute to mild hyperprolactinemia; treat and reassess the measured response.
A. Constitutional delay of puberty (Why this does not fit)
It can present with delayed puberty and low pubertal hormone values. It does not account for lifelong inability to smell; an additional developmental finding changes the differential.
B. Acquired pituitary compression (Why this does not fit)
Pituitary disease can reduce reproductive hormone stimulation. Lifelong anosmia without progressive headache or visual change favors a developmental rather than acquired process.
C. Functional hypothalamic suppression from energy deficit (Why this does not fit)
Low energy availability can suppress gonadotropins and estradiol. No energy deficit is apparent, while anosmia has been present since early childhood; use the whole history.
D. Congenital GnRH deficiency with olfactory involvement (Best answer)
Low gonadotropins with low estradiol indicate deficient central reproductive stimulation. Congenital olfactory dysfunction supports a developmental GnRH disorder; link endocrine and olfactory findings.
Takeaway: Congenital anosmia helps distinguish a developmental GnRH problem from other central causes of delayed puberty.
A. Begin full-dose combined estrogen and progestogen for absent menarche (Why this does not fit)
Estradiol and breast development are increasing without treatment. The patient is showing early puberty at 14, not established hormone failure requiring this regimen. Follow the trajectory before substituting a full replacement cycle.
B. Schedule follow-up of growth, pubertal progression and menstrual onset (Best answer)
Breast development, growth acceleration and rising estradiol demonstrate spontaneous pubertal activation. She is 14 and breast development began recently. Continue clinical follow-up, reassessing if progression stalls or new concerns appear.
C. Obtain pituitary MRI for persistent complete gonadotropin deficiency (Why this does not fit)
Progressive endogenous estrogen effects show that reproductive stimulation is occurring. The new progression and absence of neurological findings weaken this specific indication. Base further imaging on the current clinical evidence, not the earlier hormone value alone.
D. Investigate primary ovarian failure as the explanation for the current trajectory (Why this does not fit)
Inadequate estrogen output with rising compensatory FSH would support that pattern. Spontaneous breast and estradiol progression indicates active ovarian estrogen production. Interpret serial target response rather than assigning failure from earlier delay.
Takeaway: Spontaneous pubertal progression changes the interpretation of previously low hormones; continue follow-up rather than freezing the initial diagnosis.
A. Estrogen exposure is supported; outflow remains untested (Why this does not fit)
The endometrium had enough hormonal preparation to respond. At least one route was patent; external withdrawal bleeding supplies outflow evidence.
B. Normal ovulation is established; cause remains open (Why this does not fit)
The administered progestogen and its withdrawal triggered the response. A medication-induced withdrawal bleed does not demonstrate spontaneous ovulation.
C. Responsive endometrium and available outflow are supported; cause remains open (Best answer)
A hormonally responsive endometrium shed through an available outflow route. The response is compatible with anovulation but does not identify its cause; interpret challenge tests narrowly.
D. Available outflow is supported; estrogen exposure remains untested (Why this does not fit)
Blood could pass through the outflow tract. An estrogenized responsive endometrium was also needed to shed; a positive response informs both tissue and route.
Takeaway: Withdrawal bleeding supports responsive endometrium and an available route, while leaving the cause of absent spontaneous cycles unresolved.
A. Normal baseline estrogenization with spontaneous ovulation (Why this does not fit)
Estradiol was low and the endometrium was thin. A response to administered hormones does not prove spontaneous ovulation or adequate baseline estrogenization.
B. Complete outflow obstruction with normal estrogenization (Why this does not fit)
A complete barrier could prevent external bleeding. External bleeding after the combined course demonstrates an available outflow route.
C. Endometrial scarring despite estrogen priming (Why this does not fit)
An unresponsive endometrium can cause a negative withdrawal test. External bleeding after estrogen priming demonstrates responsive endometrial tissue.
D. Insufficient baseline estrogenization with responsive tissue and outflow (Best answer)
Low estradiol and a thin lining may leave too little prepared endometrium to shed. The endometrium can respond and blood can exit; paired responses favor baseline hypoestrogenism.
Takeaway: A negative progestogen response followed by bleeding after estrogen priming favors insufficient baseline estrogenization over a fixed endometrial or outlet defect.
A. Delay gonadal consultation until spontaneous puberty, then assess hormones (Why this does not fit)
The streak-like gonads, low estradiol, and high FSH show inadequate steroid production. Y-bearing dysgenetic gonads have diagnosis-specific tumor risk; prompt specialist evaluation should not wait for puberty.
B. Prompt gonadal-risk consultation with staged estrogen and uterine protection planning (Best answer)
High FSH with low estradiol and absent breasts indicates inadequate gonadal steroid output. Y-bearing streak gonads need prompt specialist risk management, and a uterus requires an appropriate pubertal hormone and later progestogen plan.
C. Plan estrogen alone indefinitely after gonadal-risk consultation (Why this does not fit)
Low endogenous sex-steroid output requires a pubertal hormone plan. A retained endometrium requires appropriate progestogen protection when estrogen treatment reaches that stage.
D. Treat presumed outflow obstruction and defer gonadal evaluation (Why this does not fit)
Imaging and examination do not identify an outflow obstruction. Streak-like Y-bearing gonads and low steroid output require gonadal-risk and hormone management.
Takeaway: 46,XY gonadal dysgenesis with a uterus requires diagnosis-specific gonadal-risk care and a hormone plan that accounts for endometrial tissue.
A. Adrenal adrenarche with primary gonadal dysfunction (Best answer)
Pubertal adrenal androgen action can produce pubic hair. High FSH with low estradiol indicates inadequate gonadal estrogen feedback; hair does not establish ovarian function.
B. Ovarian androgen excess with preserved estrogen production (Why this does not fit)
Pubertal-range DHEAS supports adrenal androgen contribution. Estradiol is low and FSH is high; use measured feedback rather than hair to assess gonadal function.
C. Adrenal adrenarche with central reproductive suppression (Why this does not fit)
Adrenal androgen action can explain pubic hair. Repeatedly high FSH is a compensatory pituitary response, favoring gonadal dysfunction over central suppression.
D. Ovarian estrogen sufficiency with isolated outflow obstruction (Why this does not fit)
An anatomical barrier can prevent external menstrual bleeding. Low estradiol, little breast development, and high FSH show inadequate ovarian estrogen feedback.
Takeaway: Pubic hair can reflect adrenal androgen action while high FSH and low estradiol indicate inadequate ovarian estrogen feedback.
A. Use estrogen treatment immediately while keeping exercise and intake unchanged (Why this does not fit)
Selected patients may need specialist consideration of hormone therapy after an appropriate trial of other intervention. Unchanged energy deficit and an unassessed stress fracture remain; address the cause and skeletal consequence first.
B. Start an oral contraceptive and assess bone health without changing intake (Why this does not fit)
A stress fracture and prolonged amenorrhea justify skeletal assessment. A contraceptive bleed can mask persistent suppression while restricted intake continues; energy restoration remains central.
C. Restore energy availability and defer bone assessment until menses return (Why this does not fit)
Improving energy availability can help restore reproductive signaling. Ten months of amenorrhea and a stress fracture already indicate skeletal risk; assessment should not wait for menses.
D. Restore energy availability with team support and assess bone health (Best answer)
Restricted intake with high exercise can suppress central reproductive signaling. Skeletal fragility warrants bone assessment while nutrition and activity are addressed; treat energy deficit and bone risk together.
Takeaway: Restore energy availability and assess skeletal injury; a contraceptive withdrawal bleed does not demonstrate recovery.
A. Retained blood is established; anovulation is confirmed (Why this does not fit)
Progesterone normally varies across the cycle and is lower outside the luteal phase. The measurement was not timed to a phase in which a luteal rise was expected. A low untimed result does not exclude a preceding or later ovulation.
B. Retained blood is established; ovulation is confirmed by monthly pain (Why this does not fit)
It suggests a cyclic process but is not a direct measurement of ovulation. The case lacks appropriately timed evidence of recent ovulation. A periodic symptom cannot replace that assessment.
C. Retained blood is established; ovulation status remains unresolved (Best answer)
Blood has reached the vagina and accumulated behind an outlet barrier. A single low value at an unknown cycle phase does not establish ovulation status. Interpret an anatomical collection separately from a time-dependent hormone test.
D. An ovarian source of blood is established; anovulation is confirmed (Why this does not fit)
Imaging localizes the blood within the vagina behind an outlet barrier, not within an ovarian cyst. An untimed low progesterone also fails to confirm anovulation. Both anatomical location and measurement timing must fit the conclusion.
Takeaway: The blood collection establishes retention; an untimed low progesterone does not establish whether ovulation occurred.
